- Previous Close
49.34 - Open
49.30 - Bid --
- Ask --
- Day's Range
48.64 - 50.45 - 52 Week Range
36.61 - 60.92 - Volume
375,726 - Avg. Volume
515,679 - Market Cap (intraday)
2.287B - Beta (5Y Monthly) -1.69
- PE Ratio (TTM)
-- - EPS (TTM)
-4.38 - Earnings Date May 7, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
74.25
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
soleno.lifeRecent News: SLNO
View More
Performance Overview: SLNO
Trailing total returns as of 3/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SLNO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SLNO
View MoreValuation Measures
Market Cap
2.26B
Enterprise Value
2.02B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
9.23
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-45.06%
Return on Equity (ttm)
-87.35%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-175.85M
Diluted EPS (ttm)
-4.38
Balance Sheet and Cash Flow
Total Cash (mrq)
291.44M
Total Debt/Equity (mrq)
21.55%
Levered Free Cash Flow (ttm)
-7.47M
Research Analysis: SLNO
View MoreCompany Insights: SLNO
SLNO does not have Company Insights
Research Reports: SLNO
View MoreDaily – Vickers Top Buyers & Sellers for 10/04/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 09/03/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 08/08/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 04/04/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.